SOHO 2022 Tenth Annual Meeting

 

SOHO 2022 Tenth Annual Meeting
J

SOHO 2022: CAR T-Cells in Indolent B-Cell Lymphomas

By SOHO 2022 Tenth Annual Meeting FEATURING Jeremy Abramson
By SOHO 2022 Tenth Annual Meeting FEATURING Jeremy Abramson
87 views
October 13, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Lymphoma
10:00

SOHO 2022: Biology and Treatment of LGL Leukemia

SOHO 2022 Tenth Annual Meeting

T. Loughran

166 views
10:35

SOHO 2022 Next Questions: Hodgkin Lymphoma

SOHO 2022 Tenth Annual Meeting

N. Bartlett

239 views
10:19

Next Questions: Mantle Cell Lymphoma

SOHO 2022 Tenth Annual Meeting

K. Maddocks

71 views
11:27

SOHO 2022 Next Questions: T-Cell Lymphoma

SOHO 2022 Tenth Annual Meeting

S. Iyer

44 views
12:37

SOHO 2022 Next Questions: Follicular Lymphoma

SOHO 2022 Tenth Annual Meeting

G. Salles

79 views
15:31

SOHO 2022: What's Next in Aggressive B-Cell Lymphoma?

SOHO 2022 Tenth Annual Meeting

L. Sehn

456 views
10:34

SOHO 2022 Next Questions: Cellular Therapy

SOHO 2022 Tenth Annual Meeting

K. Komanduri

190 views
16:19

SOHO 2022 DEBATE: CAR T-Cell vs. AUTO HCT for R/R DLBCL - Pro AUTO H…

SOHO 2022 Tenth Annual Meeting

C. Sauter

29 views
12:05

SOHO 2022 DEBATE: CAR T-Cell vs. AUTO HCT for R/R DLBCL - Pro CAR T-…

SOHO 2022 Tenth Annual Meeting

M. Kamdar

49 views
08:34

SOHO 2022: Camidanlumab Tesirine - Updated Efficacy and Safety in Pa…

SOHO 2022 Tenth Annual Meeting

A. Herrera

27 views
16:42

SOHO 2022: Treating Hodgkin Lymphoma After Brentuximab Vedotin and A…

SOHO 2022 Tenth Annual Meeting

A. Herrera

149 views
16:18

SOHO 2022: Sequencing Novel Agents in Frontline and Second-Line Trea…

SOHO 2022 Tenth Annual Meeting

A. Moskowitz

235 views
07:04

Phase 1/2 BRUIN Study - Updated Results on Pirtobrutinib in Previous…

SOHO 2022 Tenth Annual Meeting

J. Cohen

118 views
19:47

Emerging Treatment Options for MCL

SOHO 2022 Tenth Annual Meeting

J. Ruan

57 views
13:18

Immunotherapeutic Options for Patients With MCL Who Progress on BTK …

SOHO 2022 Tenth Annual Meeting

J. Cohen

80 views
14:31

The Role of Targeted Therapies in Frontline Treatment of MCL

Tycel Phillips

127 views
16:52

Is it Time to Recognize the Biological Heterogeneity of MCL?

SOHO 2022 Tenth Annual Meeting

A. Goy

82 views
08:47

SOHO 2022: Cost-Effectiveness of Polatuzumab Vedotin in Previously U…

SOHO 2022 Tenth Annual Meeting

J. Burke

27 views
08:56

SOHO 2022: Results from POLARIX, a Phase III Study of Pola-R-CHP vs.…

SOHO 2022 Tenth Annual Meeting

C. Flowers

274 views
13:55

SOHO 2022: Managing the Elderly Patient With Aggressive B-cell Lymph…

SOHO 2022 Tenth Annual Meeting

C. Thieblemont

29 views
11:32

SOHO 2022: CNS Prophylaxis in DLBCL

SOHO 2022 Tenth Annual Meeting

V. Orellana-Noia

54 views
14:57

SOHO 2022: Treatment of Aggressive B-cell Lymphoma Post-CAR T-Cell T…

SOHO 2022 Tenth Annual Meeting

G. Nowakowski

25 views
15:19

SOHO 2022: The Emerging Potential of Bispecific Antibodies as Monoth…

SOHO 2022 Tenth Annual Meeting

M. Dickinson

111 views
15:03

SOHO 2022: Choosing CAR T-Cell Therapy vs. ASCT in R/R Aggressive B-…

SOHO 2022 Tenth Annual Meeting

M. Kamdar

159 views
15:33

SOHO 2022: Has R-CHOP Really Been Replaced as Initial Therapy of DLB…

SOHO 2022 Tenth Annual Meeting

J. Friedberg

996 views
05:56

SOHO 2022: Pivotal Results From a Phase I/II Study of Mosunetuzumab …

SOHO 2022 Tenth Annual Meeting

L. Nastoupil

40 views
19:37

SOHO 2022: Using Biology to Determine Type and Duration of Treatment…

SOHO 2022 Tenth Annual Meeting

P. Kapoor

18 views
15:04

SOHO 2022: Future Role of Bispecific Antibodies in the Treatment of …

SOHO 2022 Tenth Annual Meeting

E. Budde

32 views
15:37

SOHO 2022: What Is the Role of Transplantation for FL in the Era of …

SOHO 2022 Tenth Annual Meeting

M. Hamadani

20 views
15:08

SOHO 2022: Sequencing Therapy in Indolent Lymphoma - Treatment Choic…

SOHO 2022 Tenth Annual Meeting

L. Nastoupil

277 views
10:04

SOHO 2022: Correlation of TRBC1 by Flow Cytometry With Molecular T-C…

SOHO 2022 Tenth Annual Meeting

T. Dexter

15 views
14:13

SOHO 2022: Advances in the Treatment of NK/T Cell Lymphoma

SOHO 2022 Tenth Annual Meeting

W. Kim

30 views
16:35

SOHO 2022: Integrating Novel Agents Into the Management of Cutaneous…

SOHO 2022 Tenth Annual Meeting

P. Allen

76 views
15:40

SOHO 2022: Novel Treatment Approaches in Relapsed/Refractory PTCL

SOHO 2022 Tenth Annual Meeting

M. Lunning

14 views
15:49

SOHO 2022: The Next Rational Therapeutic Regimen in Newly Diagnosed …

SOHO 2022 Tenth Annual Meeting

N. Mehta-Shah

28 views
14:21

SOHO 2022: From Bench to Bedside - A Translational Scientist's Persp…

SOHO 2022 Tenth Annual Meeting

F. Vega

20 views
21:46

SOHO 2022: CAR T-Cells in Indolent B-Cell Lymphomas

SOHO 2022 Tenth Annual Meeting

J. Abramson

87 views
18:24

SOHO 2022: Challenging Cases in Rare T-Cell Lymphomas

SOHO 2022 Tenth Annual Meeting

S. Barta

22 views
11:16

SOHO 2022: Basis for Targeting the Microenvironment in Hodgkin Lymph…

SOHO 2022 Tenth Annual Meeting

C. Steidl

79 views
11:27

SOHO 2022: CAR T-Cell Therapy in Hodgkin Lymphoma

SOHO 2022 Tenth Annual Meeting

C. Ramos

22 views
13:22

SOHO 2022: The Next Generation of Novel Agents in Development for Ag…

SOHO 2022 Tenth Annual Meeting

J. Westin

238 views